Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Sabanto provides a Farming-as-a-Service tool that transforms existing tractors into fully autonomous machines.
Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.
Syntax Bio is a biotechnology company that develops a cell programming platform to control stem cell differentiation for research.
Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.
Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.
AgZen develops pesticide sprays stick to plants which reduces pollution and helps farmers save.
Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.
NILO Therapeutics is a biotechnology and therapeutics company.
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.
Estes Energy is a California-based startup developing advanced, U.S.-made, chemistry-agnostic battery packs for mobility and industry.
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
Grove Biopharma is a biotechnology company offering a materials science solution to peptide therapeutic challenges.
Solu Therapeutics Platform Company that develops antibody-based medicines using a degradable warhead.
Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.
CH4 Global mission is to use sustainable aquaculture to impact climate change at scale.
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.
MycoWorks is a biotechnology company that offers non-plastic and non-animal materials to the market.
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.
Valar Labs offers assistance services for cancer treatment through Artificial Intelligence.
Unlearn.AI combines AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials.
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
Totus Medicines employs uses AI/ML and innovative DNA-encoded covalent library tech to discover small molecule medicines.
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
AbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes.
DCVC Bio has invested in 56 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
DCVC Bio's top investment sectors include Biotechnology, Medical, Therapeutics, Pharmaceutical, Health Care. The firm invests across 30 different industry categories.
Among tracked funding rounds, AbCellera received $515.8M in a Grant round. DCVC Bio's total known invested capital is $3.1B.
DCVC Bio's average investment size is $54.8M across its portfolio of 56 companies.
Recent DCVC Bio portfolio additions include Sabanto, Alchemab Therapeutics, SyntaxBio, Latus Bio, Sidewinder Therapeutics. These companies were founded in 2020 or later.